CVRdatabase
Menu

Alkalon A/S

Public limited companyCVR 30273826GlostrupActive

Alkalon A/S is a public limited company, based in Glostrup, active in research and experimental development on natural sciences and engineering, founded in 2007. The company made a loss in both 2024 and 2025, most recently DKK 3.6m. Equity fell to DKK 2.8m in 2025. 6 people are registered in the company's management and ownership.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 1.7m−49.9% vs. 2024
Net profit−DKK 3.6m−155.1% vs. 2024
EquityDKK 2.8m−55.7% vs. 2024
Employees5latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 50% (2024 → 2025), to DKK 1.7m.
  • The loss grew: from DKK 1.4m to DKK 3.6m (2024 → 2025).
  • Equity fell 56% (2024 → 2025), to DKK 2.8m.

Employees

  • 1 fewer employees than a year earlier: 5 (08/2026) against 6 (08/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4mDKK 6mDKK 8m202020212022202320242025
EquityNet profit
Financial figures for Alkalon A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit2,9003,3826,4496,4003,4411,724−49.9%
Operating profit (EBIT)−1,638−5282,1851,660−399−1,870−368.3%
Profit before tax−2,247−1,1881,475666−1,397−3,562−155.1%
Net profit−2,247−1,1881,475666−1,397−3,562−155.1%
Total assets24,07324,77523,36523,86320,37624,416+19.8%
Equity6,8355,6467,1227,7886,3912,829−55.7%
Liabilities17,23819,12816,24316,07513,98521,587+54.4%
Cash and cash equivalents7668161,4607992,1881,443−34.1%
Average number of employees5444550%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5mDKK 6m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 56% from 2024 to 2025 (DKK 6.4m to DKK 2.8m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Alkalon A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202517/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202415/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202308/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202203/03/2023The companyPDFXBRL
202101/01/2021 – 31/12/202125/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202004/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123456709/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 1.7mNo. 168 of 421
Better than 60% of the companies in the industry
EquityDKK 2.8mNo. 204 of 431
Better than 53% of the companies in the industry
Number of employees5No. 203 of 431
Better than 53% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 34,025of 69,742
Better than 51%
No. 20,046of 69,964
Better than 71%
Same industry and fewer than 20 employees329 companies in the comparison
No. 97of 323
Better than 70%
No. 118of 329
Better than 64%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 16,351of 24,791
Better than 34%
No. 12,665of 24,909
Better than 49%
All companies of type A/S18,025 companies in the comparison
No. 14,946of 17,786
Better than 16%
No. 13,525of 18,024
Better than 25%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Alkalon A/SDKK 1.7m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Alkalon A/S−DKK 3.6m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Alkalon A/SDKK 2.8m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Alkalon A/S5
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Alkalon A/S

Management

5 active registrations

Executive management

Executive management at Alkalon A/S
NameRoleAppointed
Kristian UggerhøjCEO01/03/2022

Board of directors

Board of directors at Alkalon A/S
NameRoleAppointed
Rasmus Forup HelmichBoard member19/05/2017
Søren FæsterChair of the board12/10/2018
Thor Nels AndersenBoard member04/02/2019
Peter SølbeckBoard member12/03/2020
Auditor
Buus Jensen I/S Statsautoriserede Revisorer
Founders
Commerce Pharma Holding ApS
Former management (31)
Former management at Alkalon A/S
NameRoleAppointedResigned
Thomas ErikssonDirector25/06/200713/01/2010
Tonni Bülow-NielsenBoard member18/09/200720/12/2007
Mats LundwallBoard member18/09/200727/03/2014
Ulla Brockenhuus-SchackBoard member27/03/200827/03/2014
Bo TandrupCEO09/04/200827/03/2014
Pál HelmichChair of the board13/01/201030/04/2015
Frank KnudsenBoard member13/01/201028/05/2010
Line Holten ReimerBoard member28/05/201030/04/2012
Torben Alexander von LowzowBoard member30/04/201227/03/2014
Bo TandrupBoard member27/03/201424/02/2017
Bjarne Carsten PedersenDirector27/03/201403/02/2019
Thomas Bjerregaard ThomsenBoard member27/03/201429/04/2015
Ulf Lennart RosénBoard member27/03/201419/05/2017
Thomas Bjerregaard ThomsenChair of the board30/04/201508/06/2016
Anne Christine BeckBoard member23/09/201503/05/2017
Rasmus Forup HelmichBoard member02/11/201630/04/2017
Robin James Scott CridlandBoard member02/11/201601/10/2017
Thor Nels AndersenBoard member24/02/201703/05/2017
Peter SølbeckBoard member19/05/201724/10/2018
Mark Rupert TuckerBoard member19/05/201713/06/2017
Nicholas Cecil MarksChair of the board19/05/201713/06/2017
Mark Rupert TuckerChair of the board14/06/201718/09/2017
Nicholas Cecil MarksBoard member14/06/201729/05/2019
Thor Nels AndersenBoard member02/10/201715/08/2018
Robin James Scott CridlandChair of the board02/10/201703/09/2018
Søren FæsterBoard member15/08/201811/10/2018
Bjarne Carsten PedersenCEO04/02/201916/03/2020
Rolf EckersbergBoard member24/01/202031/12/2021
Rolf EckersbergCEO16/03/202016/04/2021
Jan WaageCEO16/04/202131/12/2021
Preben AndersenCEO01/01/202228/02/2022

Signing rule: Selskabet tegnes af tre bestyrelsesmedlemmer eller af selskabets administrerende direktør og bestyrelsesformanden i forening.

Address and production units

1 active production units

Farverland 6
2600 Glostrup

Albertslund Municipality · Postcode 2600

Other companies at the address (1)

Production units
Production unitAddressEmployeesP number
Alkalon A/SFarverland 6, st, 2600 Glostrup51020242910

Purpose

Selskabets formål er at udvikle, registrere og kommercialisere nye generiske lægemidler til den farmaceutiske industri og dermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

122 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20224 changesaccounts 1 · management 3
  • Annual report for 2021 published
  • Kristian Uggerhøj appointed ceo
  • Preben Andersen stepped down as ceo
  • Preben Andersen appointed ceo
20215 changesmanagement 4 · accounts 1
  • Jan Waage stepped down as ceo
  • Rolf Eckersberg stepped down as board member
  • Annual report for 2020 published
  • Jan Waage appointed ceo
  • Rolf Eckersberg stepped down as ceo
20206 changescapital 2 · management 4
  • Share capital changed from 2,856,806 DKK to 4,120,172 DKK
  • Rolf Eckersberg appointed ceo
  • Bjarne Carsten Pedersen stepped down as ceo
  • Peter Sølbeck appointed board member
  • Share capital changed from 2,773,598 DKK to 2,856,806 DKK
  • Rolf Eckersberg appointed board member
20197 changescapital 1 · management 4 · ownership 2
  • Share capital changed from 1,699,417 DKK to 2,773,598 DKK
  • Nicholas Cecil Marks stepped down as board member
  • Metropolitan Capital Partners Limited is no longer registered as owner
  • Itaconix Plc (U.K.) is no longer registered as owner
  • Bjarne Carsten Pedersen appointed ceo
  • Thor Nels Andersen appointed board member
  • Bjarne Carsten Pedersen stepped down as director
20187 changesmanagement 6 · capital 1
  • Peter Sølbeck stepped down as board member
  • Søren Fæster appointed chair of the board
  • Søren Fæster stepped down as board member
  • Robin James Scott Cridland stepped down as chair of the board
  • Søren Fæster appointed board member
  • Thor Nels Andersen stepped down as board member
  • Share capital changed from 6,633,650 DKK to 1,699,417 DKK
201723 changesaddress 1 · management 18 · capital 2 · ownership 2
  • Moved to Farverland 6, st, 2600 Glostrup
  • Robin James Scott Cridland appointed chair of the board
  • Thor Nels Andersen appointed board member
  • Robin James Scott Cridland stepped down as board member
  • Mark Rupert Tucker stepped down as chair of the board
  • Share capital changed from 6,449,318 DKK to 6,633,650 DKK
  • Nicholas Cecil Marks appointed board member
  • Mark Rupert Tucker appointed chair of the board
  • Mark Rupert Tucker stepped down as board member
  • Nicholas Cecil Marks stepped down as chair of the board
  • Share capital changed from 2,949,318 DKK to 6,449,318 DKK
  • Peter Sølbeck appointed board member
  • Mark Rupert Tucker appointed board member
  • Nicholas Cecil Marks appointed chair of the board
  • Rasmus Forup Helmich appointed board member
  • Ulf Lennart Rosén stepped down as board member
  • SEED CAPITAL DENMARK K/S is no longer registered as owner
  • Metropolitan Capital Partners Limited registered as owner (20%)
  • Thor Nels Andersen stepped down as board member
  • Anne Christine Beck stepped down as board member
  • Rasmus Forup Helmich stepped down as board member
  • Thor Nels Andersen appointed board member
  • Bo Tandrup stepped down as board member
201616 changescapital 2 · management 3 · ownership 11
  • Share capital changed from 2,506,920 DKK to 2,949,318 DKK
  • Rasmus Forup Helmich appointed board member
  • Robin James Scott Cridland appointed board member
  • Itaconix Plc (U.K.) registered as owner (20%)
  • NOLTA ApS registered as owner (33.33%)
  • SØLCO ApS registered as owner (25%)
  • NOLTA ApS is no longer registered as owner
  • SØLCO ApS is no longer registered as owner
  • Share capital changed from 2,078,479 DKK to 2,506,920 DKK
  • Thomas Bjerregaard Thomsen stepped down as chair of the board
  • NOLTA ApS registered as owner (15%)
  • SØLCO ApS registered as owner (15%)
  • PreSeed Ventures A/S is no longer registered as owner
  • NOLTA ApS is no longer registered as owner
  • COMMERCE PHARMA HOLDING ApS is no longer registered as owner
  • SØLCO ApS is no longer registered as owner
20155 changesaddress 1 · management 4
  • Moved to Naverland 1, 14, 2600 Glostrup
  • Anne Christine Beck appointed board member
  • Thomas Bjerregaard Thomsen appointed chair of the board
  • Pál Helmich stepped down as chair of the board
  • Thomas Bjerregaard Thomsen stepped down as board member
201415 changescapital 1 · ownership 6 · management 8
  • Share capital changed from 1,677,115 DKK to 2,078,479 DKK
  • PreSeed Ventures A/S registered as owner (5%)
  • SEED CAPITAL DENMARK K/S registered as owner (33.33%)
  • NOLTA ApS registered as owner (10%)
  • HELMICH INVEST ApS registered as owner (33.33%)
  • COMMERCE PHARMA HOLDING ApS registered as owner (10%)
  • SØLCO ApS registered as owner (10%)
  • Ulf Lennart Rosén appointed board member
  • Thomas Bjerregaard Thomsen appointed board member
  • Bjarne Carsten Pedersen appointed director
  • Bo Tandrup appointed board member
  • Torben Alexander von Lowzow stepped down as board member
  • Bo Tandrup stepped down as ceo
  • Ulla Brockenhuus-Schack stepped down as board member
  • Mats Lundwall stepped down as board member
20122 changesmanagement 2
  • Torben Alexander von Lowzow appointed board member
  • Line Holten Reimer stepped down as board member
20112 changescapital 2
  • Share capital changed from 1,630,820 DKK to 1,677,115 DKK
  • Share capital changed from 1,538,229 DKK to 1,630,820 DKK
20107 changescapital 2 · management 5
  • Share capital changed from 1,445,638 DKK to 1,538,229 DKK
  • Line Holten Reimer appointed board member
  • Frank Knudsen stepped down as board member
  • Share capital changed from 1,167,861 DKK to 1,445,638 DKK
  • Frank Knudsen appointed board member
  • Pál Helmich appointed chair of the board
  • Thomas Eriksson stepped down as director
20092 changescapital 1 · address 1
  • Share capital changed from 768,746 DKK to 1,167,861 DKK
  • Moved to Vesterbrogade 149, 1620 København V
20087 changescapital 3 · name 1 · management 2 · industry 1
  • Share capital changed from 545,670 DKK to 768,746 DKK
  • Name changed from ALKALON ApS to ALKALON A/S
  • Share capital changed from 181,890 DKK to 545,670 DKK
  • Bo Tandrup appointed ceo
  • Share capital changed from 162,660 DKK to 181,890 DKK
  • Ulla Brockenhuus-Schack appointed board member
  • Industry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20079 changesmanagement 4 · capital 1 · industry 2 · name 1 · founded 1
  • Tonni Bülow-Nielsen stepped down as board member
  • Share capital changed from 125,000 DKK to 162,660 DKK
  • Tonni Bülow-Nielsen appointed board member
  • Mats Lundwall appointed board member
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
  • Name changed from BO TANDRUP ApS to ALKALON ApS
  • Thomas Eriksson appointed director
  • Industry changed to Anden virksomhedsrådgivning (741490)
  • Registered as BO TANDRUP ApS

Related companies

Same industry in Albertslund

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction